Engineered Halomonas for Production of Gamma-Aminobutyric Acid and 2-Pyrrolidone

Ge Zhang,Weike Guo,Xueqing Yi,Zhongnan Zhang,Lizhan Zhang,Xu Liu,Fuqing Wu,Qiong Wu,Guo-Qiang Chen
DOI: https://doi.org/10.1016/j.biortech.2024.131448
IF: 11.4
2024-01-01
Bioresource Technology
Abstract:Gamma-Aminobutyric acid (GABA) is a derivative of L-glutamate, also a precursor for the synthesis of 2-pyrrolidone, which is a monomer of nylon-4. This study achieved a one-step biosynthesis of GABA and 2-pyrrolidone by Halomonas bluephagenesis overexpressing key genes involved in GABA and 2-pyrrolidone synthesis and deleting GABA degradation genes combined with reducing the degradation of 2-pyrrolidone precursor. The resulting H. bluephagenesis strain WLp07 was employed in whole-cell catalysis, producing 357 g/L of GABA and 72 wt% of PHA. Furthermore, a self-flocculating H. bluephagenesis allowed rapid, convenient recycling of the cells, achieving 880 g/L of GABA over three cycles. Shake flask studies showed that engineered H. bluephagenesis harboring beta-alanine CoA transferase was able to synthesized 2-pyrrolidone from GABA. H. bluephagenesis as a chassis of next generation industrial biotechnology (NGIB), demonstrated its diverse ability to produce GABA and 2-pyrrolidone in addition to intracellular PHA.
What problem does this paper attempt to address?